Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3901912011 | Tazemetostat (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3901913018 | Tazemetostat | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazemetostat | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Tazemetostat | Is a | Methyltransferase inhibitor | true | Inferred relationship | Some | ||
| Tazemetostat | Has disposition | Methyltransferase inhibitor | true | Inferred relationship | Some | ||
| Tazemetostat | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Tazemetostat | Is a | Substance with benzamide structure | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazemetostat only product | Has active ingredient | True | Tazemetostat | Inferred relationship | Some | 1 |
| Tazemetostat-containing product in oral dose form | Has active ingredient | True | Tazemetostat | Inferred relationship | Some | 1 |
| Tazemetostat-containing product | Has active ingredient | True | Tazemetostat | Inferred relationship | Some | 1 |
| Tazemetostat only product in oral dose form | Has active ingredient | True | Tazemetostat | Inferred relationship | Some | 1 |
| Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet | Has BoSS | True | Tazemetostat | Inferred relationship | Some | 1 |
| Tazemetostat hydrobromide | Is modification of | True | Tazemetostat | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR